BDNF (Val66Met) genetic polymorphism is associated with vulnerability for methamphetamine dependence

Pharmacogenomics. 2015;16(14):1541-5. doi: 10.2217/pgs.15.96. Epub 2015 Sep 24.

Abstract

Aim: Association of the brain-derived neurotrophic factor (BDNF) genetic polymorphism rs6265 (Val66Met) with methamphetamine (METH) dependence and METH-induced psychosis was investigated in the Thai population.

Materials & methods: The rs6265 genotype was determined in 100 male METH-dependent subjects and 102 controls using a real-time PCR high-resolution melt (RT-PCR-HRM) assay.

Results: The rs6265 genotype demonstrated significant differences in distribution between METH-dependent subjects and controls in which the frequency of GG genotype versus A-allele carriers was associated with METH dependence. Moreover, a significant effect of genotype on the occurrence of psychosis was found, with a lower frequency of GG genotype associated with METH-induced psychosis.

Conclusion: The present findings indicate that rs6265 is associated with METH dependence in the Thai population, with the GG genotype greater in METH-dependent subjects but reducing the emergence of METH-dependent psychosis.

Keywords: BDNF; methamphetamine dependence; polymorphism; psychosis; rs6265.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amphetamine-Related Disorders / epidemiology
  • Amphetamine-Related Disorders / genetics*
  • Asian People / genetics
  • Brain-Derived Neurotrophic Factor / genetics*
  • Central Nervous System Stimulants*
  • Diagnostic and Statistical Manual of Mental Disorders
  • Gene Frequency
  • Genotype
  • Humans
  • Methamphetamine*
  • Polymorphism, Genetic / genetics*
  • Psychoses, Substance-Induced / epidemiology
  • Psychoses, Substance-Induced / genetics
  • Thailand / epidemiology

Substances

  • Brain-Derived Neurotrophic Factor
  • Central Nervous System Stimulants
  • Methamphetamine
  • BDNF protein, human